Table 3

Traditional cardiovascular risk factors and atherosclerotic plaque presence in patients with SLE

CharacteristicsSLE (n=202)
Systolic blood pressure, mm Hg (median, range)117 (109–126)
Smoking, pack-years (mean±SD)10.3±14.6
Smoking current, n (%)71 (35.1)
Family history of premature CΑD, n (%)20 (9.9)
Total Cholesterol, mg/dL (mean±SD)183±40.9
HDL, mg/dL (mean±SD)60.6±20.6
LDL, mg/dL (mean±SD)103.6±32.9
Triglycerides, mg/dL (mean±SD)101.1±61.3
BMI, kg/m2 (median, IQR)24.6 (7.9)
Exercise, min/week (mean, range)103 (0–720)
Hypertension, n (%)73 (36.1)
Dyslipidaemia, n (%)99 (49)
Antihypertensives, n (%)63 (32)
Statins, n (%)24 (11.9)
Antiplatelet agents, n (%)57 (28.2)
SCORE, median (IQR)1.7 (3)
Plaque presence (carotid and/or femoral), n (%)52 (25.7)
Carotid plaque presence, n (%)42 (20.8)
Femoral plaque presence, n (%)35 (17.3)
  • BMI, body mass index; CAD, coronary artery disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LLDAS, lupus low disease activity state; SCORE, Systematic COronary Risk Evaluation prediction of 10-year fatal cardiovascular disease.